Understanding the clinical significance of cytomegalovirus viremia after chimeric antigen receptor T-cell therapy: Should we be treating a value?
Clin Infect Dis
.
2024 Feb 2:ciae030.
doi: 10.1093/cid/ciae030.
Online ahead of print.
Authors
Eleftheria Kampouri
1
,
Michael J Boeckh
1
2
3
,
Joshua A Hill
1
2
3
Affiliations
1
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.
2
Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
3
Department of Medicine, University of Washington, Seattle, WA.
PMID:
38306247
DOI:
10.1093/cid/ciae030
No abstract available